LOINCBoth

LOINC Code 73695-9: HIV reverse transcriptase+protease+integrase gene mutations detected Nom (Isol)

73695-9 is a LOINC code used to identify HIV reverse transcriptase+protease+integrase gene mutations detected Nom (Isol) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component HIV reverse transcriptase+protease+integrase gene mutations detected. It is commonly used with the system or sample type Isolate.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component HIV reverse transcriptase+protease+integrase gene mutations detected. It is commonly used with the system or sample type Isolate.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: DEPRECATED
  • Order vs observation: Both

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

  • Deprecated HIV reverse transcriptase+protease+integrase gene mutations detected [Identifier]
  • HIV reverse transcriptase+protease+integrase gene mutations detected
  • HIV-1 genotyping resistance assay starts with the isolation of HIV-1 RNA from blood plasma, followed by amplification of the protease (PR), reverse transcriptase (RT) and integrase (IT) coding regions using sequencing methods to determine drug susceptibility. This code is based on, but not limited in use to, the submitter's test kit (GenoSure PRIme),a DNA sequence assay that detects mutations within the protease (amino acids 1-99), reverse transciptase (amino acids 1-400), and integrase (amino acids 1-288) coding regions of HIV-1. Assessment of drug susceptibility is based on the interpretation of mutations identified. It is performed to assess treatment failure, assist in choosing alternate regimens, and to assist in choosing a regimen that will reduce vertical transmission in pregnant HIV infected women. The answer list provided with this code represents example mutations that may be identified and is not a complete list.
  • AIDS; ANTIBIOTIC SUSCEPTIBILITIES; HIV RT+PR+IN; Human immunodeficiency virus; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Mut; Mut Det; Mutation; Muts; Nominal; Point in time; PR; Random; REV; RT

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

HIV reverse transcriptase+protease+integrase gene mutations detected Nom (Isol)Deprecated HIV reverse transcriptase+protease+integrase gene mutations detected [Identifier]Deprecated HIV RT+PR+IN Mut Det IsltHIV reverse transcriptase+protease+integrase gene mutations detectedABXBACTHIV reverse transcriptase+Protease+Integrase gene variant analysisPrid

Frequently asked questions

Code details

Code73695-9
SystemLOINC
Display nameHIV reverse transcriptase+protease+integrase gene mutations detected Nom (Isol)
DescriptionHIV reverse transcriptase+protease+integrase gene mutations detected
Short nameDeprecated HIV RT+PR+IN Mut Det Islt
ComponentHIV reverse transcriptase+protease+integrase gene mutations detected
PropertyPrid
TimingPt
System (specimen)Isolate
ScaleNom
ClassABXBACT
StatusDEPRECATED
Order/ObservationBoth

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.44
Last changed2.56

Consumer names

HIV reverse transcriptase+Protease+Integrase gene variant analysis

Part names

HIV reverse transcriptase+protease+integrase gene mutations detectedPridPtIsolateNomPresence or IdentityPoint in time (spot)

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.

LOINC Code 73695-9 | HealthAssure